Company ProfilePremium

T&K TOKA Corporation

Company Profile Analysis

Ticker: 4636.T株式会社T&K TOKA

ESOMAR 23 Corporate BadgeISO Certifications Badge
T&K TOKA Corporation - Company showcase

Year Founded & Workforce

1947

1,122 Employees

T&K TOKA Corporation logo

T&K TOKA Corporation Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

T&K TOKA Corporation Overview

T&K TOKA is a mid-sized Japanese specialty-ink and functional-materials maker. Its main franchise is ultraviolet (UV)-curable printing inks, a technology it commercialised in 1977. The company describes itself as Japan's market-share leader in UV inks. Bain Capital singled out that leadership as the core of its investment thesis.

Around the ink base sit two adjacent platforms:

Functional resins: epoxy hardeners, latent curing agents and dimer-acid thermoplastic resins.

Precision dispersions: colour-filter pigment dispersions for flat-panel displays, with a dedicated plant in Zhejiang, China.

Overseas operations are Asia-centric, with subsidiaries in Korea, Indonesia, Thailand, China and the US. The company also holds a roughly 30% equity-method stake in Hangzhou Toka Ink, which is listed on Shanghai's STAR Market.

The financial profile is weak. Consolidated revenue fell from ¥49.6bn (FY3/2019) to ¥43.7bn (FY3/2023), and operating margins stayed near 1%. Activist pressure from Dalton/NAVF followed, and in 2024 Bain took the company private. The equity story now rests on a privately executed turnaround under an externally recruited CEO.


Company's own description (FY3/2023 Yuho, paraphrased)

Product typeMain uses
UV inksCartons, labels, cards, pamphlets, cans
Planographic / offset inksPosters, catalogues, magazines, flyers
Flexographic inksLabels, paper bags, corrugated boxes
Gravure inksFrozen-food and confectionery bags, publications
Metal-decorating inksFood, beverage and art cans
Special functional inksFPDs, electronic substrates
Functional resinsBridge anti-corrosion paints, automotive adhesives, metal coatings, ink binders, functional films, FRP

The group makes and sells:

  • printing inks (offset, gravure and others);

  • printing machines and printing-related equipment such as blankets;

  • functional resins;

  • precision dispersion products.

It reports as a single segment ("printing ink business"). No segment-level breakdown is therefore disclosed.

The FY3/2023 Yuho lists seven main product types:

Independent characterisation

End-marketStated trend
Publication printingDeclining
Commercial printingFlat
Package printingGrowing, with sustainability the dominant theme in every field (Yuho FY3/2023)

T&K TOKA is a B2B formulator and manufacturer. Revenue is overwhelmingly product sales: the FY3/2023 Yuho reports production of ¥32.7bn at selling-price value and purchased merchandise of ¥6.0bn. There is no meaningful subscription or licensing revenue.

The approximate revenue mix (derived, FY3/2023) is:

  • about 85% manufactured products;

  • about 15% traded merchandise such as consumables and equipment (inferred from the purchased-goods figure).

Value-chain position. The company sits in the middle of the chain:

Upstream: it buys pigments, crude-oil derivatives, imported vegetable oils and monomers. Dainichiseika and Nagase are named as purchasing partners in its cross-shareholding disclosure.

Downstream: it sells inks to printers and converters (commercial, label, carton and flexible-packaging printers, can makers). It sells resins to paint, adhesive and composites makers, and dispersions to display-materials supply chains.

Customer types. Shareholdings held "to strengthen sales relationships" provide indirect evidence:

  • printing majors: Dai Nippon Printing, Toppan, Kyodo Printing;

  • packaging printers: Asahi Printing, Nozaki Insatsu Shigyo, Takeda Printing;

  • NISSHA;

  • Kansai Paint (a resin customer);

  • Shobond Holdings (bridge-repair coatings, consistent with anti-corrosion epoxy hardeners);

  • Oji Holdings.

IR Bank's profile lists Nikka Fine Techno and JSR as principal customers, consistent with the display-materials business.

End-markets.

The company also serves electronics/display (colour-filter dispersions, special inks) and industrial coatings/adhesives/composites (resins).

Business model economics

Gross margins sat in a narrow 17–19% band (FY3/2019–FY3/2023, EDINET DB calculation from Yuho data). Operating margins of 0.5–1.1% show that SG&A absorbs nearly all gross profit. Pre-tax profit therefore depended heavily on non-operating income: equity-method income, mainly from Hangzhou Toka Ink, plus dividends from cross-shareholdings and FX gains.

For example, in FY3/2023:

  • operating income was ¥424M;

  • ordinary income was ¥1,853M;

  • the ¥1.43bn gap was largely equity-method and other non-operating income.

This structure, a low-return core business supported by an associate stake and portfolio investments, is central to understanding both the activist campaign and the take-private.

Strategy

Stated strategy (listed era)

AreaPriorities
InksEB inks for flexible packaging; UV ink development and sales for labels and cartons; building infrastructure to concentrate on UV
Functional materialsLaunch the Zhejiang plant; hit new-development targets; raise capacity
FoundationsImprove IR quality; IT infrastructure; talent development

Long-term 2030 Vision (adopted 1 Jan 2021):

  • Mission: provide "truly good products for customers" through "unique technology" and contribute to society.

  • 2030 vision: become a global company where individuals and the organisation grow together and are trusted by society.

  • Management policies: customer-centric value creation; supporting and fairly evaluating employees; solving social issues through business.

2030 numerical targets: operating margin 8.0%, ROE 8.0%, payout at least 50% (tender opinion, Jan 2024).

  • Three levers: (I) specialise in products that contribute to sustainability; (II) product portfolio reform; (III) shift to problem-solving business models.

Mid-term plan "With You toward 2024" (FY3/2023–FY3/2025):

  • ESG management that balances economic and social value.

  • Allocate operating cash flow preferentially to capex, development and M&A.

  • Strengthen oversight of investments and M&A.

Bain Capital's stated post-acquisition agenda (tender opinion, Jan 2024)

Bain's thesis rested on four strengths it identified:

  • technology and development capability;

  • detailed customer service;

  • customer trust and brand power in Japan and overseas;

  • experienced people.

It committed to:

hands-on management support: through its consulting-style portfolio group;

  • strengthening talent and organisation, drawing on a Japan management-talent pool of more than 100 people;

  • M&A and post-merger integration support, including overseas.

Bain and the company agreed on two priority investment areas: next-generation UV inks and the Zhejiang precision-dispersion business. Bain said existing management would in principle be retained. That was later superseded by the appointment of an external CEO (date not disclosed).

Post-privatisation strategy (company website, 2026)

CEO Ishiai's published message, paraphrased:

  • treat the company as a team sport serving all stakeholders;

  • prioritise a safe, secure and stable foundation;

  • build continuous earning power, sharp-edged technology, rigorous quality and fast execution;

  • support all of this through people development, a "global one team" and a rewarding workplace.

The homepage frames the mission as building a global enterprise that keeps challenging change "through talent development and speedy management reform". Medium-term financial targets are not publicly disclosed since privatisation.

Initiatives register (last 24 months and immediately prior)

InitiativeDateStatus / target
Sale of Hangzhou Toka shares below 30% (China mandatory-offer avoidance)Nov 2023Completed; ¥1.95bn proceeds
Exit from Russia/Iran-linked business2,023Completed (tender condition)
Withdrawal of seconded officers from Hangzhou Toka; unwinding of certain related-party transactions2,023Completed (tender condition)
Tohoku Toka Shikiso business transferMar 2024Completed
External CEO recruitment (Ishiai)Post-2024, date not disclosedCompleted
Shift to auditor-based governance with sponsor boardPost-2024Completed
Parent headcount reduction (636 → 610)Mar 2023 – Apr 2026Ongoing; no programme announced
Sustainability: TCFD endorsement; women ≥40% of hires and ≥5% of managers by Mar 2025; 100% parental-leave uptakeSet 2022–2023Outcome not publicly disclosed
Cost programmes with numerical targets——

Products & Services

Pricing is not disclosed for any product line. Launch years are given only where documented.

Inks

Product lineDescription / capabilitiesTarget customersLaunch / latestFlagship notes
General UV inks (UV offset)Cure instantly under UV light; hard films; print on paper, film and metalCarton, label, card and commercial printersFirst launched 1977; ongoing "new-type UV inks compliant with various regulations" (FY3/2023 R&D)Company claims No.1 domestic share in UV inks (website meta-description)
Special UV inksHigh-functionality UV inks; the Yuho singles out special UV inks as the company's strength and priority for capexSpecialty and security printers, can makersOngoingNamed as a top priority for operating cash-flow allocation (Yuho MD&A)
UV flexo inksUV-curable flexographic inks with a "global-spec" formulationLabel printers worldwideFY3/2023 R&D theme—
Low-energy / LED-compatible UV inksImproved curability under power-saving UV lampsPrinters converting to LED-UVFY3/2023 R&D themeLow-energy curability is a stated sustainability lever
Low-migration UV inksFor food-contact packaging (Preqin product list)Food packaging converters——
Biomass-mark certified UV inksPlant-derived content certified under Japan's biomass mark (Preqin product list)Brand owners with sustainability goals——
EB (electron-beam) curable inksSolvent-free inks for flexible packaging; less odour, higher safety, lower environmental burden than solvent gravureFlexible-packaging converters"Environment-friendly EB printing inks" in development (FY3/2023)Strategic priority in FY3/2024 plan; cited as the shift from solvent ink in tender docs
Sheet-fed offset inksConventional oil-based lithographic inksCommercial printersMatureDeclining market
Web (rotary) offset inksFor web pressesPublication/commercial printersMatureDeclining market
Waterless offset inksFor silicone-plate waterless printingWaterless printersMature—
Flexographic inks (solvent / water-based)For flexible relief plates on paper and filmLabel, paper-bag and corrugated convertersOngoingShift to water-based and UV
Gravure inksIntaglio inks for high-volume runsFood packaging, publicationsOngoingEB inks positioned as the replacement for solvent gravure
Metal-decorating inksBaked or UV-cured inks on tinplate and aluminiumCan makers (food, beverage, art cans)Ongoing—
Special functional inksInks for electronics, FPDs and circuit boardsElectronics makersOngoing—
Primers / metal paintsCoating products (Preqin list)Industrial——

Functional materials

Product lineDescriptionTarget customersNotes
Colour-filter pigment dispersionsFine pigment dispersions that improve display colour reproductionColour-filter and FPD panel makers (JSR and Nikka Fine Techno cited as principal customers by IR Bank)Sharp FY3/2023 volume drop on FPD inventory correction; production localised at the Zhejiang plant
Nano-dispersion productsVarious nano-scale dispersionsElectronics/materialsFY3/2023 R&D "new fields" theme
Dispersion × resin-synthesis hybridsFunctional materials combining both core technologiesIndustrialFY3/2023 R&D theme
Waterborne epoxy hardenersImprove the working environment for painting work (low VOC)Anti-corrosion paint makers (bridge coatings)Performance enhancement in FY3/2023
Low-temperature latent curing agentsImprove performance of electrical parts and energy efficiency in manufacturingElectronics adhesive formulatorsPerformance enhancement in FY3/2023
Epoxy hardeners (general)Curing agents for epoxy resinsPaint, adhesive and FRP makersLegacy Fuji Kasei line
Dimer-acid thermoplastic resinsPolyamide-type resins from dimerised fatty acidsInk binders, adhesivesPreqin product list
Hydrophobic resinsWater-repellent resinsCoatingsPreqin product list
Composite materialsResin systems for FRPComposite fabricatorsPreqin product list
High-performance resins (various)Petroleum- and bio-based organic synthesisInk, paint, adhesive, film makersOngoing

Machinery & consumables

Product lineDescriptionNotes
Printing machinesPrinting presses (traded/agency)Shown as "machine products" on the website
Printing-related equipmentBlankets and other consumablesPart of ¥5.96bn purchased merchandise (FY3/2023)

Financial Narrative

Sources: audited consolidated figures from Yuho FY3/2019–FY3/2023 (EDINET), compiled by EDINET DB. JPY millions unless noted. Japanese GAAP.

Income statement

Supplementary notes:

  • Diluted EPS is not captured in this research. Dilution was immaterial: only 30,400 option shares were outstanding in Jan 2024.

  • FY3/2023 pre-tax income (税金等調整前当期純利益) was ¥1,855M (Yuho cash-flow statement). Other years' pre-tax figures are not captured separately, so ordinary income is shown as the pre-tax proxy.

Revenue CAGR FY3/2019–FY3/2023 (derived): −3.2% per year: EDINET DB's 3-year CAGR is also −3.2%.

  • Reference — the longer-run peak: revenue ¥53.0bn in FY3/2013 and operating income ¥2.9bn (6.0% margin) in FY3/2015 (EDINET DB).

Commentary.

  1. Revenue. Revenue fell 15% between FY3/2019 and FY3/2021. Causes were structural decline in publication and commercial printing, compounded by COVID-19 in FY3/2021 (−12.5%). FY3/2022 recovered (+5.3%) on price increases and overseas growth. FY3/2023 slipped again (−1.8%): ink sales rose on price pass-through and overseas expansion, but colour-filter dispersion shipments collapsed amid the FPD inventory correction (Yuho FY3/2023 MD&A).

  2. Margin compression. Operating margin collapsed from 4.0% (FY3/2018) to 0.7% (FY3/2019) and stayed at or below 1.1% thereafter. The inflection coincides with:

    • the Van Son (Dec 2017) and Midwest Ink (Dec 2018) acquisitions;

    • start-up costs of the Zhejiang dispersion plant;

    • raw-material inflation. The company never recovered its pre-2018 5–6% margin despite repeated price revisions.

  3. Below-the-line dependence. In every year, ordinary income was 2–9 times operating income. The difference came from equity-method income, mainly Hangzhou Toka, plus dividends and FX. In FY3/2023, equity-method gains of ¥635M were deducted as non-cash in the cash-flow statement.

  4. Net income volatility. FY3/2022 net income (¥2.65bn) was boosted by a special gain on the sale of fixed assets at the Hong Kong subsidiary. FY3/2020 (¥158M) was depressed by impairments and other charges, not detailed here. FY3/2023 fell 58% because the HK gain did not recur.

  5. Dividends. The FY3/2021 DPS cut to ¥15 (COVID) was reversed to ¥40 in FY3/2022. The FY3/2023 payout ratio reached 81.2% against a medium-term target of at least 50%.

Interim and forecast data for FY3/2024 (last public figures)

Sources: Q3 FY3/2024 results (7 Feb 2024); company notice of 27 Nov 2023. The forecast revision reflected a ¥955M consolidated gain on the Hangzhou Toka share sale.

Interpretation: nine-month operating income rose 52% YoY. This suggests price pass-through and cost actions were gaining traction just as the company went private. Audited FY3/2024 and all later results are not publicly disclosed.

Balance sheet

Notes:

  • The short- vs long-term debt split is not captured in this research. The FY3/2023 Yuho shows short-term borrowings down ¥1,441M, long-term borrowings down ¥740M, and the current portion of long-term debt down ¥68M.

  • The cash figure is "cash and deposits". Cash & equivalents at FY3/2023 was ¥2,828M (Yuho), down ¥3,417M after time-deposit placements and debt repayment.

  • At FY3/2023, PP&E was ¥23,929M and investment securities ¥12,748M. Together (¥36.7bn) they made up 54.1% of total assets (Yuho risk factor 3).

Commentary. The balance sheet was conservative:

  • the equity ratio rose to 71.7%;

  • debt/equity fell to 0.12x;

  • on EDINET DB's "net cash" measure (current assets minus total liabilities), the company held ¥9.9bn.

FY3/2020 borrowing (debt +¥4bn) funded the Zhejiang plant and Midwest Ink and provided COVID liquidity; it was paid down over FY3/2021–FY3/2023.

The key valuation anomaly was that the stock traded at 0.4–0.5x book, and the tender price of ¥1,410 was below BPS of ¥2,136 (30 Jun 2023). The board argued that book value overstated liquidation value because special-purpose plant could not be monetised at carrying value (tender opinion, Jan 2024).

Cash flow

Supplementary items (not available for all five years, so not tabulated):

Capex (accrual): ¥1,358M in FY3/2023, of which Saitama production equipment was ¥544M and the Zhejiang plant build-out ¥407M. Cash purchases of PP&E were ¥1,288M (Yuho FY3/2023).

Dividends paid: ¥1,128M in FY3/2023 (Yuho).

Share buybacks: ¥715M in 2020; ¥1,333M in 2016 (IR Bank). FY3/2023 saw ¥236M of treasury-share purchases via the directors' share-delivery trust (Yuho).

Depreciation & amortisation: ¥2,255M in FY3/2023 (Yuho).

Commentary. Operating cash flow was consistently positive (¥2.1–3.2bn), but trended down. FY3/2023 free cash flow (¥361M) did not cover the ¥1.13bn dividend, so the gap was funded from cash balances. That was unsustainable at a public-company payout of 81%. This is one reason a private owner with lower distribution requirements and a longer horizon was credible.

Ratios

Notes:

  • FY3/2020 payout is derived (DPS ¥34 / EPS ¥6.7). EDINET DB leaves it blank.

Interest coverage: and cash conversion cycle are not publicly disclosed in the sources captured. Interest expense was not separately extracted.

Commentary. Capital efficiency was the weakest point. ROE never exceeded 5.8% and averaged about 2.6%. That is far below the company's own 2030 target of 8% and the TSE Prime market's implied cost of equity.

The TSE's 2023 push for companies trading below 1x PBR to address capital efficiency, combined with Dalton/NAVF's 25% stake, made the status quo untenable.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

Metric (single segment, JPY Mn)FY3/2021FY3/2022FY3/2023

Segment revenue (JPY Mn)

42,20544,45643,667

Segment operating income (JPY Mn)

198228424

Segment operating margin (%)

0.50.51.0

Segment revenue YoY growth (%)

-12.55.3-1.8

Share of total revenue (%)

100100100

Internal Business Line Details

Internal business lineContentsDisclosed revenue

Printing inks

UV (general, special, low-migration, biomass-certified), offset (sheet-fed, web, waterless), flexo (solvent, water-based, UV), gravure, metal-decorating, EB-curable inks

—

Functional materials — precision dispersions

Colour-filter pigment dispersions, nano-dispersions

Not disclosed. FY3/2023 shipments of CF dispersions "fell sharply" because of FPD oversupply.

Functional materials — resins

Epoxy hardeners (incl. waterborne), low-temperature latent curing agents, dimer-acid thermoplastic resins, hydrophobic resins, composite materials

—

Machines & consumables

Printing machines, blankets, printing-related equipment (largely traded merchandise)

Not disclosed. Purchased merchandise was ¥5,959M in FY3/2023, +11.2% YoY.

“—” = not publicly disclosed.

Group Entities

EntityLocationOwnershipRole

T&K TOKA Co., Ltd.

Saitama, Japan

Parent

Manufacturing, R&D, sales

Tohoku Toka Shikiso

Sendai, Japan

100%

Regional sales (business transferred Mar 2024)

Korea Special Ink Industry

Incheon, Korea

100%

Ink manufacturing & sales

PT Cemani Toka

Bogor, Indonesia

72.58%

Ink manufacturing & sales

Toka (Thailand)

Samut Prakan, Thailand

49.00% (consolidated)

Sales

Zhejiang Dike Toka Fine Chemical (浙江迪克東華精細化工)

Jiaxing, Zhejiang, China

100%

Precision dispersions plant; ¥3,405M intragroup loan

T&K TOKA U.S.A., Inc.

Illinois, USA

100%

US holding/sales; ¥641M loan

Van Son Holland Ink Corp. of America

Illinois, USA

100% (indirect)

Ink manufacturing; ¥894M loan

Midwest Ink Co.

Illinois, USA

100% (indirect)

Ink

Hangzhou Toka Ink Co., Ltd.

Hangzhou, China

33.50% → ≈29.90% after Nov 2023 sale (derived)

Equity-method associate; STAR Market-listed

Sanwa Gosei

Kaohsiung, Taiwan

37.65%

Equity-method associate

Seven other associates

Various

—

Not individually disclosed (includes Bangladesh and Saudi JVs historically)

Income Statement and Margin Analysis (%)

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

Revenue (JPY Mn)

49,63848,21742,20544,45643,667

Gross profit (JPY Mn, derived from reported gross margin)

8,8368,8247,8088,4027,598

Operating income (JPY Mn)

368546198228424

EBITDA (JPY Mn, EDINET DB calc.)

2,9382,9142,2742,3542,679

Ordinary income / pre-tax proxy (JPY Mn)

1,0951,2931,0881,9921,853

Net income attributable to owners (JPY Mn)

6271581,3232,6511,107

EPS basic (JPY)

26.76.758.4117.649.3

Dividend per share (JPY)

3434154040

Gross margin (%)

17.818.318.518.917.4

Operating margin (%)

0.71.10.50.51.0

EBITDA margin (%, derived)

5.96.05.45.36.1

Net margin (%)

1.30.33.16.02.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

Metric (JPY Mn)9M to Dec 20229M to Dec 2023FY3/2024 original forecastFY3/2024 revised forecast (27 Nov 2023)

Revenue

33,53034,31745,50045,500

Operating income

505770900900

Ordinary income

2,2052,2892,6002,600

Net income

1,5171,9851,5001,920

EPS (JPY)

67.588.366.7785.46

Balance Sheet and Margin Analysis (%)

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

Total assets (JPY Mn)

65,88867,95067,43570,30667,845

Cash and deposits (JPY Mn)

4,8576,5346,3156,2452,828

Interest-bearing debt (JPY Mn)

6,52810,4919,3618,2485,818

Net debt (JPY Mn)

1,6713,9573,0462,0032,990

Net assets / equity (JPY Mn)

44,29342,95744,74348,29649,124

Current assets (JPY Mn)

31,48333,81431,16131,34128,651

Current liabilities (JPY Mn, derived from current ratio)

17,39418,99717,60518,43615,742

Working capital (JPY Mn, derived)

14,08914,81713,55612,90512,909

Inventories (JPY Mn)

7,5578,0257,5987,9558,341

Retained earnings (JPY Mn)

42,30941,66840,42842,62942,607

Equity ratio (%)

66.662.565.668.071.7

BPS (JPY)

1,866.41,805.71,965.72,121.12,172.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

Operating cash flow (JPY Mn)

3,0102,5273,2272,2952,108

Investing cash flow (JPY Mn)

-1,458-3,484-772-971-1,747

Financing cash flow (JPY Mn)

-1,1142,707-2,643-1,725-3,981

Free cash flow, OCF + ICF (JPY Mn)

1,552-9572,4551,324361

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

ROE (%)

1.40.43.15.82.3

ROA (%)

1.00.22.03.81.6

ROIC (%, EDINET DB calc.)

0.81.20.40.50.8

Current ratio (%)

181178177170182

Debt to equity (x)

0.150.240.210.170.12

Net debt to EBITDA (x, derived)

0.571.361.340.851.12

Asset turnover (x, derived)

0.750.710.630.630.64

Financial leverage (x)

1.491.581.511.461.38

Dividend payout (%)

127.3507.525.734.081.2

Revenue by Region (%) and Revenue by Region

MetricFY3/2022FY3/2023

Overseas sales ratio (%)

35.237.8

Overseas revenue (JPY Mn, derived)

15,64916,506

Japan revenue (JPY Mn, derived)

28,80727,161

Region Overview

RegionOperationsTrajectory

Japan

Saitama and Shiga plants plus branch production (Chiba, Nagoya, Osaka, Fukuoka)

Declining; branch network repeatedly consolidated (2020, 2022, 2024)

China

Zhejiang dispersion plant (consolidated); Hangzhou Toka Ink (≈30% associate)

Associate strong; Zhejiang in ramp-up/loss phase (¥3.4bn intragroup loan)

Korea

Korea Special Ink (115 employees)

Stable

Southeast Asia

Indonesia (266 employees), Thailand

Growth markets for packaging

North America

Van Son USA, Midwest Ink (Illinois)

Sub-scale; supported by intragroup loans

Europe

Van Son B.V. liquidated Oct 2022

Exited

Russia / Iran

Orders from these countries had to be cancelled as a Bain tender condition

Exited (2023)

Per-Share Data and Valuation Multiples (x)

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

Year-end share price (JPY, derived = PER × EPS)

9267068538941,075

P/E at year-end (x)

34.7105.314.67.621.8

P/B at year-end (x)

0.500.390.430.420.49

Dividend yield (%)

3.664.821.764.503.72

Share Price & Returns

PeriodReturn

≈1-year (from ¥1,075, Mar 2023)

+31%

≈3-year (from ¥853, Mar 2021)

+65%

≈5-year (from ¥926, Mar 2019)

+52%

Per-Share Data

MetricFY3/2019FY3/2020FY3/2021FY3/2022FY3/2023

DPS (JPY)

3434154040

Analyst Conclusions

Guidance and consensus

Management guidance: none published since privatisation. The last guidance was for FY3/2024: revenue ¥45.5bn, operating income ¥0.9bn, ordinary income ¥2.6bn, net income ¥1.92bn.

Consensus: none (no analyst coverage).

Bull case

  1. Margin-recovery runway. Operating margin of 1.0% (FY3/2023) against peers at 5–6% and the company's own pre-2018 level of 5–6%. Closing even half that gap on ¥45bn of revenue would add roughly ¥1.0–1.5bn of operating profit (derived). Nine-month FY3/2024 operating income was already up 52%.

  2. UV/EB structural tailwind. Leadership in UV inks and an early EB position address the fastest-growing, sustainability-driven segment of packaging print.

  3. Hidden asset value. ≈29.9% of Hangzhou Toka, ¥12.7bn of investment securities and land at historical cost give the sponsor levers to deleverage and fund M&A without diluting the operating business.

Bear case

  1. Structural decline outpaces reform. Revenue CAGR of −3.2% and an 18% fall from the peak suggest that core offset and publication ink volumes will keep shrinking, eroding the fixed-cost base faster than restructuring can respond.

  2. Display-materials bet may disappoint. Zhejiang absorbed ¥3.4bn of intragroup loans, yet FY3/2023 CF dispersion shipments collapsed. Chinese panel-supply chains are highly price-competitive.

  3. Execution and leverage risk. Leadership changed twice in about two years (Masuda → Takamizawa → Ishiai). The new governance model has no independent directors, and LBO debt adds fragility if raw-material or FX shocks recur.

Key catalysts and monitorables (next 12 months)

  • Any statutory financial-statement notice revealing FY3/2025 or FY3/2026 performance.

  • Bain-backed add-on acquisitions, especially overseas UV or packaging-ink assets.

  • Further sell-downs of the Hangzhou Toka stake or cross-shareholdings.

  • Zhejiang plant utilisation and display-market recovery.

  • EB ink commercial wins in flexible packaging.

  • Further domestic site consolidation or headcount changes.

  • Signals of a Bain exit (trade sale to a strategic such as a larger ink group, secondary sale, or relisting), typically 3–5 years after a 2024 entry, i.e. 2027–2029.

Analyst verdict

T&K TOKA is a textbook case of a Japanese mid-cap whose technological franchise outgrew its listed-company governance. The core asset is real: nearly five decades of UV-ink know-how, a claimed domestic share lead, and integrated resin and dispersion chemistry. Yet that asset earned an operating margin of about 1% and ROE of about 2–3% for five straight years. The shares traded at half of book value.

Ownership pressure built in stages:

  • activist Dalton/NAVF accumulated about 25%;

  • an MBO proposal surfaced and was withdrawn;

  • a partial tender offer failed;

  • the TSE's capital-efficiency push added a final catalyst.

The board responded with a credible process, running an independent special committee and a competitive auction. The outcome was a Bain take-private at ¥1,410 that delivered roughly 50–65% price upside to multi-year holders, though still below book value.

The investment question has therefore shifted from public-market valuation to private turnaround execution. Bain's playbook is unusually well suited to this situation:

  • an external, globally experienced CEO in Nobumasa Ishiai;

  • a sponsor-controlled board;

  • footprint consolidation, already visible in headcount and subsidiary rationalisation;

  • optional M&A funded partly by non-core assets.

The early evidence was encouraging: nine-month FY3/2024 operating income rose 52% before delisting. Nothing since then is publicly verifiable.

Our assessment is constructive but low-visibility. Upside rests on margin normalisation toward the 5–8% range, scaling of EB and next-generation UV, and monetising the Hangzhou stake. Downside rests on secular print decline, display-materials cyclicality and leverage. For counterparties such as suppliers, customers and potential acquirers, T&K TOKA should be viewed as a sponsor-owned specialty-ink platform likely to be repositioned for a strategic or financial exit within about 2027–2029. For credit and supply-chain risk, its pre-deal balance-sheet strength (71.7% equity ratio) offers some cushion. Monitor any disclosure of the acquisition debt quantum.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleBackground (where verified)

Nobumasa Ishiai (石合 信正)

Representative Director, President & CEO

Formerly President & Representative Director of Cabot Japan K.K. (US specialty chemicals). Earlier: Senior Executive Officer and CEO of the Japan/Asia LifeScience business group at Arysta LifeScience; SVP of Invensys Climate Controls Asia-Pacific and President & CEO of Ranco Japan; COO/President of GE Polymerland Japan at General Electric. BA in Commerce, Keio University (GLOBIS Insights profile). Author of books on bringing "foreign-company speed" into Japanese firms. Appointment date not publicly disclosed.

Yuji Takei (竹井 友二)

Director

—

Shoji Suekane (末包 昌司)

Director

—

Yuriro Ogawa (小川 由理郎)

Director

—

Kei Komachi (小町 景)

Corporate Auditor (Kansayaku)

—

Satoshi Ueyama (上山 聡)

Corporate Auditor

—

Kazuhiko Nakama (中間 和彦)

Managing Executive Officer, CTO

Born 1967. In FY3/2023 he was Managing Director heading the Ink Business HQ.

Hideaki Sekine (関根 秀明)

Managing Executive Officer, CFO

Born 1968. In FY3/2023 he was Managing Director, head of Management HQ and Finance Dept.

Board of Directors

NameTitleBornTenure / notes

Akihiro Takamizawa

Representative Director, President

1,970

Joined 1994. General Manager of Hangzhou Toka Ink from 2008. Director from June 2021. Not on the current board.

Kazuhiko Nakama

Managing Director, Ink Business HQ

1,967

Owned 13,000 shares

Hideaki Sekine

Managing Director, Management HQ & Finance

1,968—

Kenji Otaka

Outside Director (A&SC member)

1,952

Since June 2015; Southeast Asia business expertise

Satoshi Noguchi (野口 郷司)

Outside Director (A&SC chair; Nomination Committee chair)

1,952

Since June 2017; former listed-company executive

Koichi Hanabusa

Outside Director (A≻ Remuneration Committee chair)

1,958

Certified public accountant

Hideaki Kimura

Outside Director (A&SC)

1,962

Since June 2022; attorney; former Vice-President of the Tokyo Bar Association

Governance Detail

CategoryHeadcountTotal (JPY Mn)FixedPerformance cashNon-monetary (stock)

Internal directors

61771502640

Outside directors

8393900

Major Shareholders

HolderStake

Dalton Investments, Inc. (Dalton LLC reported as "other affiliated company", 19.28% voting)

19.13%

Master Trust Bank of Japan (trust a/c)

7.42%

Koshibi (Masuda family asset vehicle)

4.65%

Mizuho Bank (incl. 4.34% retirement-benefit trust via Mizuho Trust)

4.36%

NAVF PLC

3.98%

Meiji Yasuda Life

3.34%

Mikako Ueda

3.29%

Azuchi Masuda

3.25%

Yoshikatsu Masuda

3.21%

Hiromi Masuda

2.84%

Asuka Masuda

2.55%

NAVF Select LLC

1.49%

Competitive Landscape

Competitors by Segment

Business lineCompetitorHQNotes

Printing inks (global)

DIC Corporation (incl. Sun Chemical)

Japan

World's largest ink group.

Printing inks

artience Co., Ltd. (formerly Toyo Ink SC Holdings)

Japan

FY12/2025 revenue ≈¥350bn (the-shashi.com, from Yuho)

Printing inks

Sakata INX Corporation

Japan

FY12/2024 revenue ¥245,570M, OI ¥13,161M. FY12/2025 revenue ≈¥257.7bn, OI ≈¥15.2bn. Overseas share 74.5% (FY12/2025).

Printing inks

Flint Group

Luxembourg/Europe

—

Printing inks

Siegwerk Druckfarben

Germany

—

Printing inks

hubergroup

Germany

—

UV / screen / special inks

Teikoku Printing Inks Mfg.

Japan

—

UV / special inks

Jujo Chemical

Japan

—

China inks

Hangzhou Toka Ink (also an affiliate) and domestic Chinese makers

China

Simultaneously partner and competitor in China

Colour-filter dispersions

Toyocolor (artience group), Mikuni Color, other pigment-dispersion makers

Japan

—

Epoxy hardeners / latent curing agents

Evonik, Mitsubishi Chemical, ADEKA, Ajinomoto Fine-Techno

Global/Japan

—

Peer Comparison FY2012

MetricT&K TOKA (FY3/2023)Sakata INX (FY12/2024)Sakata INX (FY12/2025)artience (FY12/2025)

Revenue (JPY Bn)

43.7245.6257.7350.0

Revenue growth (%)

-1.87.54.9—

Operating margin (%)

1.05.45.9—

R&D intensity (%)

2.1———

ROE (%)

2.3—10.0—

Recent Developments

*Disclosure caveat. The 18 months to October 2026 fall entirely within private ownership. The company publishes almost no material news beyond website updates.

Guidance revisions, litigation, layoffs or new contract wins after

Company Snapshot

$310.8M

Revenue

1,122

Employees

1947

Founded

Saitama, Japan

Headquarters

SWOT Analysis

Strengths

  • UV ink leadership. First commercialised UV inks in April 1977; claims No.1 domestic UV share (website). Bain cited its UV ink track record as a key reason for investing (tender opinion, Jan 2024).
  • Conservative balance sheet. Equity ratio 71.7%, D/E 0.12x and net debt of only ¥2.99bn against equity of ¥49.1bn at FY3/2023 (Yuho).
  • Valuable China associate. Its ≈30% stake in STAR Market-listed Hangzhou Toka Ink generates sizeable equity income. Selling just 3.6% of Hangzhou's shares raised ¥1.95bn in Nov 2023.
  • Integrated technology base. Ink formulation, resin synthesis and precision dispersion are all in-house (Yuho R&D section). This enables products such as low-temperature latent curing agents and CF dispersions.
  • Consistent operating cash generation. Operating cash flow was positive every year, between ¥2.1bn and ¥3.2bn over FY3/2019–FY3/2023.
  • Long-tenured, stable workforce. Average service of 16.2 years (FY3/2023 Yuho), supporting customer-service depth that Bain specifically valued.

Weaknesses

  • Chronically low profitability. Operating margin was 0.5–1.1% from FY3/2019 to FY3/2023, against 5.4–5.9% at Sakata INX (FY12/2024–25).
  • Poor capital efficiency. ROE averaged ≈2.6% and ROIC was 0.4–1.2% (EDINET DB), far from the 8% target in the 2030 Vision.
  • Shrinking top line. Revenue CAGR was −3.2% over FY3/2019–FY3/2023, and revenue is down 18% from the FY3/2013 peak of ¥53.0bn.
  • Earnings depend on non-operating items. Ordinary income of ¥1,853M versus operating income of ¥424M in FY3/2023.
  • Sub-scale overseas operations. Van Son Netherlands was liquidated within five years of acquisition. The US units depend on ¥1.5bn of intragroup loans (Yuho FY3/2023).
  • Weak diversity metrics. Women held 0.9% of management roles and 0% of board seats (FY3/2023).

Opportunities

  • Solvent-to-EB conversion in flexible packaging. A strategic priority in which T&K TOKA claims an early position (Yuho FY3/2023; tender opinion).
  • LED / low-energy UV and recyclability. These are explicit R&D themes.
  • Zhejiang precision-dispersion ramp-up. ¥3.6bn of plant book value plus a ¥3.4bn loan already invested (Yuho), offering operating leverage when display demand recovers.
  • Bain-supported M&A. The tender opinion explicitly envisions overseas acquisitions with post-merger integration support.
  • Asset monetisation. ¥12.7bn of investment securities and a remaining ≈29.9% Hangzhou stake can fund deleveraging or growth.
  • Domestic footprint optimisation. Branch consolidations in 2020, 2022 and 2024 show room for further cost-out under private ownership.

Threats

  • Structural print decline. The Yuho states that publication printing is decreasing and commercial printing flat.
  • Raw-material and energy inflation. Crude-oil derivatives and imported vegetable oils are primary inputs (risk factor 2), and FY3/2023 saw significant cost pressure.
  • FPD cyclicality. CF dispersion shipments fell sharply in FY3/2023 on panel oversupply.
  • Scale competitors. DIC, artience and Sakata (revenue ¥245–350bn and above) can outspend T&K TOKA on R&D and global service.
  • Geopolitical and regulatory exposure. Russia/Iran business had to be cut. Operations in China are subject to evolving economic-security rules (risk factor 7).
  • LBO leverage. Acquisition debt from two domestic banks (amount not disclosed) may constrain investment if the turnaround stalls.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
4 Aug 2023Q1 FY3/2024: revenue ¥10,833M (−2.2%), operating income ¥78M (−76%)Weak start to the year
17 Aug 2023Board endorses planned Bain tender offer at ¥1,400; tender agreements for 27.42%Take-private announced
18 Aug 2023Corrections to the 17 Aug releaseProcedural
21 Sep 2023Further tender agreements (cumulative 32.18%)Deal certainty rises
13 Oct 2023Serbian merger clearance found unnecessaryCondition removed
18 Oct 2023Employee shareholding association (3.15%) resolves to tenderSupport broadens
20 Oct 2023Hulic, Nagase and others sign tender agreements (cumulative 36.23% incl. ESOP)—
7 Nov 2023H1 FY3/2024: revenue ¥22,048M, operating income ¥197M (−39%)—
24 Nov 2023Board resolves partial sale of Hangzhou Toka sharesChina TOB workaround
27 Nov 2023Sale completed (RMB93.15M); net income forecast raised to ¥1,920MSpecial gain ¥955M
29 Nov 2023China TOB measures notified as complete; purchasers confirmedCondition satisfied
15 Dec 2023Japan Fair Trade Commission prior notification filed by BainAntitrust
20 Dec 2023JFTC issues notice of no cease-and-desist orderAntitrust cleared
4–5 Jan 2024Share price closes above the offer price (¥1,433 and ¥1,455)Market pressure for a bump
9 & 18 Jan 2024Progress announcements on TOB commencement—
22 Jan 2024Price raised to ¥1,410; Dalton Group tender and 15% reinvestment agreementActivist bloc (24.59%) locked up
23 Jan 2024Tender offer commences—
7 Feb 2024Q3 FY3/2024: revenue ¥34,317M (+2.3%), operating income ¥770M (+52.4%), net income ¥1,985M (+30.8%)Last public results
14 Feb 2024NAVF large-shareholding report shows 0% (shares committed/tendered)—
28 Feb 2024Record date set for an extraordinary shareholders' meetingContingency plan
6 Mar 2024Tender offer closes successfully—
7 Mar 2024Results announced; EGM cancelled because BCJ-74 exceeded 90%Squeeze-out route available
13 Mar 2024Settlement; BCJ-74 holds 90.99% of voting rightsChange of control
Mar 2024Tohoku Toka Shikiso business transferredDomestic rationalisation
27 Mar 2024Board approves BCJ-74's share-sale demandSqueeze-out
24 Apr 2024Last trading day (close ¥1,405); delisting notice—
25 Apr 2024Delisted from TSE PrimePrivate company
2024 (date n/d)CEO Ishiai gives external lectures (Mar, May–Jun, Jul, Nov, Dec 2024 per website)Visible external CEO
Post-2024 (date n/d)Board reconstituted (Ishiai, Takei, Suekane, Ogawa); auditor-based governance; Nakama becomes CTO and Sekine CFOSponsor governance
1 Apr 2026Parent headcount reported at 610Modest downsizing vs 636 (Mar 2023)

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Segment revenue rose from JPY 42,205 Mn in 2021 to JPY 43,667 Mn in 2023.
T&K TOKA Corporation — Revenue by Segment
Series (JPY Mn)202120222023
Segment revenue42,20544,45643,667
Segment operating income198228424

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. T&K TOKA Annual Securities Report (Yuho), 81st term, FY3/2023, filed 23 Jun 2023 (EDINET S100R1WE), plus prior Yuho data FY3/2012–FY3/2022 via EDINET DB.
  2. T&K TOKA, "Announcement of Opinion in Support of and Recommendation to Tender in Tender Offer … by K.K. BCJ-74", 22 Jan 2024 (English reference translation).
  3. T&K TOKA notices on TSE/JPX: TOB results (7 Mar 2024), squeeze-out approval (27 Mar 2024), delisting (24 Apr 2024), EGM record date and cancellation (28 Feb and 7 Mar 2024).
  4. T&K TOKA, "Notice Concerning Completion of Sale of Certain Shares of an Equity-Method Affiliate…", 27 Nov 2023.
  5. T&K TOKA quarterly results FY3/2023–FY3/2024 (via Kabutore / EDINET DB).
  6. Nippon Active Value Fund PLC RNS, 6 Jan 2023: Alliance News, 22 Jan 2024.
  7. Company website toka-global.com (company outline, history, top message), accessed Oct 2026.
  8. GLOBIS Insights profile of Nobumasa Ishiai: Preqin portfolio profile · IR Bank snapshot (24 Apr 2024) · Ropes & Gray attorney deal list.
  9. Sakata INX FY12/2024 results presentation (Feb 2025): CREX / the-shashi.com compilations for Sakata INX and artience FY12/2025.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.